Capital International Sarl Boosts Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Capital International Sarl grew its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 4.3% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 7,067 shares of the biotechnology company’s stock after buying an additional 291 shares during the period. Capital International Sarl’s holdings in Axon Enterprise were worth $2,211,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Vanguard Group Inc. raised its position in shares of Axon Enterprise by 2.7% during the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock valued at $2,547,878,000 after buying an additional 212,401 shares in the last quarter. Sands Capital Management LLC grew its holdings in shares of Axon Enterprise by 0.6% during the 4th quarter. Sands Capital Management LLC now owns 2,628,652 shares of the biotechnology company’s stock valued at $679,060,000 after purchasing an additional 16,347 shares during the last quarter. Norges Bank bought a new position in shares of Axon Enterprise during the 4th quarter valued at $195,406,000. Westfield Capital Management Co. LP grew its holdings in shares of Axon Enterprise by 5.1% during the 4th quarter. Westfield Capital Management Co. LP now owns 731,721 shares of the biotechnology company’s stock valued at $189,025,000 after purchasing an additional 35,528 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Axon Enterprise by 2.8% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 580,757 shares of the biotechnology company’s stock valued at $150,027,000 after purchasing an additional 15,840 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Down 0.1 %

Shares of AXON traded down $0.22 during trading hours on Friday, reaching $310.59. 347,880 shares of the company traded hands, compared to its average volume of 488,656. The company’s fifty day moving average price is $294.49 and its two-hundred day moving average price is $291.73. The company has a market capitalization of $23.44 billion, a price-to-earnings ratio of 90.82, a price-to-earnings-growth ratio of 7.06 and a beta of 0.95. The company has a quick ratio of 2.55, a current ratio of 2.91 and a debt-to-equity ratio of 0.37. Axon Enterprise, Inc. has a 12 month low of $175.37 and a 12 month high of $329.87.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.95 by $0.20. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. The company had revenue of $460.74 million during the quarter, compared to analysts’ expectations of $441.57 million. During the same period last year, the company posted $0.51 EPS. Axon Enterprise’s revenue was up 34.3% on a year-over-year basis. Equities research analysts predict that Axon Enterprise, Inc. will post 2.35 earnings per share for the current fiscal year.

Insider Activity at Axon Enterprise

In related news, Director Jeri Williams sold 308 shares of Axon Enterprise stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $310.07, for a total transaction of $95,501.56. Following the completion of the transaction, the director now directly owns 1,607 shares of the company’s stock, valued at approximately $498,282.49. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other Axon Enterprise news, Director Julie A. Cullivan sold 993 shares of Axon Enterprise stock in a transaction dated Friday, May 31st. The shares were sold at an average price of $281.72, for a total value of $279,747.96. Following the completion of the transaction, the director now directly owns 4,553 shares of the company’s stock, valued at $1,282,671.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jeri Williams sold 308 shares of Axon Enterprise stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $310.07, for a total transaction of $95,501.56. Following the completion of the transaction, the director now directly owns 1,607 shares of the company’s stock, valued at $498,282.49. The disclosure for this sale can be found here. Insiders sold a total of 89,447 shares of company stock valued at $27,684,677 in the last three months. Company insiders own 6.10% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently commented on AXON shares. Bank of America started coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $380.00 target price on the stock. Morgan Stanley increased their target price on shares of Axon Enterprise from $285.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, April 26th. JMP Securities reissued a “market outperform” rating and issued a $375.00 price target on shares of Axon Enterprise in a report on Tuesday, May 7th. Jefferies Financial Group started coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 price target on the stock. Finally, Barclays raised their price target on shares of Axon Enterprise from $308.00 to $381.00 and gave the stock an “overweight” rating in a report on Wednesday, May 8th. Two research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $342.54.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.